|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Center for Complementary and Alternative Medicine (NCCAM) |
| Information provided by: | National Center for Complementary and Alternative Medicine (NCCAM) |
| ClinicalTrials.gov Identifier: | NCT00200889 |
Purpose
This study will determine how acupuncture affects human brain activity.
| Condition | Intervention | Phase |
|
Healthy |
Procedure: Manual acupuncture Procedure: Electro-acupuncture Procedure: Sensory stimulation |
Phase I |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Single Blind, Placebo Control, Crossover Assignment, Efficacy Study |
| Official Title: | Exploring Neurocircuitry of Acupuncture Action With fMRI |
| Estimated Enrollment: | 60 |
| Study Start Date: | May 2005 |
| Estimated Study Completion Date: | May 2009 |
| Estimated Primary Completion Date: | May 2009 (Final data collection date for primary outcome measure) |
Acupuncture is an ancient Chinese practice involving the insertion of needles into specific parts of the body for therapeutic purposes. Although the practice has become more popular in the West, the underlying mechanisms of acupuncture have not been thoroughly examined. This study will determine how acupuncture affects human brain activity, particularly during deqi, a unique sensation experienced during acupuncture that is considered essential to the clinical effectiveness of the practice.
This study will comprise 2 clinic visits. At Visit 1, participants will be randomly assigned to receive manual acupuncture; electro-acupuncture, which passes an electrical current through the needles; or some type of sensory stimulation. At Visit 2, participants will again be randomly assigned to receive one of the three interventions. As participants receive their assigned intervention, they will undergo functional magnetic resonance imaging (fMRI) brain scans. Participants will also have their heart rate monitored during the brain scans.
Eligibility
| Ages Eligible for Study: | 18 Years to 55 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Vitaly Napadow, PhD | 617-724-3402 | vitaly@nmr.mgh.harvard.edu |
| United States, Massachusetts | |||||
| Massachusetts General Hospital | Recruiting | ||||
| Boston, Massachusetts, United States, 02114 | |||||
| Contact: Lauren LaCount llacount@nmr.mgh.harvard.edu | |||||
| Principal Investigator: Vitaly Napadow, PhD | |||||
| Principal Investigator: | Vitaly Napadow, PhD | Harvard University |
More Information
| Responsible Party: | Massachusetts General Hospital Dept. of Radiology ( Vitaly Napadow, Ph.D. ) |
| Study ID Numbers: | K01 AT002166-01 |
| First Received: | September 13, 2005 |
| Last Updated: | February 27, 2008 |
| ClinicalTrials.gov Identifier: | NCT00200889 |
| Health Authority: | United States: Federal Government |
|
|